Clinical Trials Directory

Trials / Completed

CompletedNCT01624012

Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist Versus Nasal Continuous Airway Pressure in Premature Infants

Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist (NIV NAVA) Versus Nasal Continuous Airway Pressure (NCPAP) in Premature Infants

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
University of Oulu · Academic / Other
Sex
All
Age
1 Hour – 48 Hours
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare if a new noninvasive ventilation mode (NIV NAVA) is better in noninvasive ventilation of premature infants than currently used Nasal Continuous Airway Pressure (ncpap), and if NIV NAVA gives real benefits for patients or not. The investigators study hypothesis is that with NIV NAVA the invasive ventilation is more synchronous with patient, which will lead to a decrease in need of inspired oxygen.

Conditions

Interventions

TypeNameDescription
DEVICENIV NAVANon invasive ventilation with neurally adjusted ventilatory assist
DEVICENasal continuous positive airway pressureNoninvasive respiratory support with continuous positive airway pressure

Timeline

Start date
2011-08-01
Primary completion
2015-08-01
Completion
2016-05-01
First posted
2012-06-20
Last updated
2016-05-12

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01624012. Inclusion in this directory is not an endorsement.